BridgeBio Pharma Inc. (BBIO)
NASDAQ: BBIO
· Real-Time Price · USD
38.22
-0.14 (-0.36%)
At close: May 01, 2025, 3:13 PM
BridgeBio Pharma Revenue
BridgeBio Pharma reported an annual revenue of $221.9M, reflecting a 2285.27% growth. For the quarter ending March 31, 2025, BridgeBio Pharma generated $116.63M in revenue.
Revenue (ttm)
$221.9M
Revenue Growth
2285.27%
Price / Sales Ratio
23.01
Revenue / Employee
$306.07K
Employees
725
Market Cap
7.26B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 221.9M | +2285.27% |
| Dec 31, 2023 | 9.3M | -88.02% |
| Dec 31, 2022 | 77.65M | +11.38% |
| Dec 31, 2021 | 69.72M | +745.14% |
| Dec 31, 2020 | 8.25M | n/a |